Radical radiotherapy for early nonsmall cell lung cancer

International Journal of Radiation Oncology, Biology, Physics

Volumn 31, Issue 2, 1995, Pages 261-266

  Graham, Peter H ^a   Gebski, Val J ^a   Stat, M ^a   Langlands, Allan O ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Curative radiotherapy; Nonsmall cell lung cancer

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; ESOPHAGITIS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MORBIDITY; NAUSEA; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; RADIATION PNEUMONIA; SKIN TOXICITY; TREATMENT OUTCOME; TUMOR VOLUME; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; MORBIDITY; NEOPLASM STAGING; RADIOTHERAPY; REGRESSION ANALYSIS; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 0028799670     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)E0137-9     Document Type: Article

References (34)

1. Radical irradiation with the split-course technique in carcinoma of the lung
2. Radiotherapy for lung cancer
3. Radical radiotherapy for carcinoma of the bronchus: An equal alternative to radical surgery?
4. Lung cancer: Diagnosis, staging and therapy
5. Radiotherapy alone for patients with operable carcinoma of the lung
6. 2 (clinical) nonsmall cell carcinoma of the lung: Prospective trials of radiation therapy with total doses of 60 Gy by the Radiation Therapy Oncology Group
7. 5-year survival after hyperfractionated radiation therapy for nonsmall-cell carcinoma of the lung (NSCCL): Results of RTOG protocol 81-08
8. The role of curative radiotherapy in the treatment of lung cancer
9. Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies
10. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
11. Prognostic factors in patients with resected stage I nonsmall cell lung cancer
12. Results of radical radiation therapy in clinical Stage I and clinically operable nonsmall lung cancer
13. Primary lung cancer: Characterisation and survival of 1024 patients treated in a single institution
14. TNM classification of malignant tumors
15. The present position relating to cancer of the lung; results with radiotherapy alone
16. Radiotherapy of bronchogenic carcinoma
17. 1 disease in carcinoma of the lung
18. On the elicitation of preferences for alternative therapies
19. Fallacy of the 5-year survival in lung cancer
20. The treatment of carcinoma of the bronchus: A clinical trial to compare surgery and supervoltage radiotherapy
21. Surgical therapy in lung cancer: Biologic, physiologic, and technical determinants
22. Radical radiotherapy for bronchogenic carcinoma: 5-year survival rates
23. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer
24. Long-term observation of the patterns of failure in patients with unresectable nonoat cell carcinoma of the lung treated with definitive radiotherapy
25. Ten year follow-up of a comprehensive rehabilitation program for severe COPD
26. The influence of tumor size and pretreatment staging on outcome following radiation therapy alone for Stage I nonsmall cell lung cancer
27. Can lung cancer be cured by radiation alone?
28. Nonsmall cell carcinoma of the lung. A retrospective study
29. Curative radiotherapy in nonsmall cell carcinoma of the lung
30. Survival of patients treated surgically for Stage I lung cancer
31. Prognosis of lung cancer detected in communitywide tuberculosis surveys: An analysis of 906 cases
32. Curative radiotherapy of early operable nonsmall-cell lung cancer
33. Appraisal for the study of chemotherapy of cancer in man, comparative therapeutic trial of nitrogen mustard and triethylene thiosphosphoramide